On the other hand, IFNαR1−/− mice exhibited resistance to weight gain and were dependent on type I IFN responses originating in macrophages, which indicates that the selective induction of type I IFN in ATMs may provide a new strategy for treating obesity [133]. The gene discussed is IFNAR1; the disease is obesity due to melanocortin 4 receptor deficiency.